Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
68.89
+2.20 (3.30%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Inspire Medical Systems Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,992 | 2,680 | 5,555 | 6,006 | 7,277 | 6,294 | |
Market Cap Growth | -12.34% | -51.76% | -7.51% | -17.47% | 15.63% | 24.23% |
Enterprise Value | 1,700 | 2,390 | 5,170 | 5,567 | 6,859 | 6,115 |
Last Close Price | 68.89 | 92.23 | 185.38 | 203.43 | 251.88 | 230.06 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.95 | 18.43 | 103.82 | - | - | - |
Forward PE | 50.67 | 57.14 | 114.37 | - | - | - |
PS Ratio | 2.22 | 2.94 | 6.92 | 9.61 | 17.84 | 26.97 |
PB Ratio | 2.41 | 3.43 | 8.06 | 10.49 | 14.67 | 27.48 |
P/TBV Ratio | 2.41 | 3.43 | 8.06 | 10.49 | 14.67 | 27.48 |
P/FCF Ratio | 17.01 | 34.15 | 60.96 | 5865.34 | 2942.75 | - |
P/OCF Ratio | 12.68 | 22.91 | 42.65 | 243.63 | 629.04 | - |
PEG Ratio | - | 9.93 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.89 | 2.62 | 6.44 | 8.91 | 16.82 | 26.20 |
EV/EBITDA Ratio | 23.83 | 36.82 | 121.26 | - | - | - |
EV/EBIT Ratio | 31.41 | 46.90 | 143.27 | - | - | - |
EV/FCF Ratio | 14.52 | 30.45 | 56.73 | 5436.59 | 2773.55 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.04 | 0.04 | 0.05 | 0.04 | 0.02 | 0.15 |
Debt / EBITDA Ratio | 0.37 | 0.45 | 0.66 | - | - | - |
Debt / FCF Ratio | 0.25 | 0.41 | 0.35 | 24.26 | 3.59 | - |
Net Debt / Equity Ratio | -0.35 | -0.35 | -0.60 | -0.76 | -0.89 | -0.79 |
Net Debt / EBITDA Ratio | -4.09 | -4.25 | -9.70 | 11.64 | 9.68 | 4.67 |
Net Debt / FCF Ratio | -2.49 | -3.52 | -4.54 | -425.32 | -178.95 | 7.28 |
Asset Turnover | 1.04 | 1.06 | 1.08 | 1.01 | 0.95 | 0.81 |
Inventory Turnover | 0.85 | 1.18 | 2.16 | 4.22 | 4.54 | 2.59 |
Quick Ratio | 5.96 | 4.46 | 6.09 | 7.05 | 8.38 | 6.02 |
Current Ratio | 8.55 | 6.08 | 7.13 | 7.60 | 8.66 | 6.50 |
Return on Equity (ROE) | 17.96% | 19.77% | 8.48% | -3.96% | -12.38% | -18.33% |
Return on Assets (ROA) | 3.91% | 3.71% | 3.04% | -4.05% | -6.92% | -8.64% |
Return on Invested Capital (ROIC) | 10.10% | 13.05% | 16.00% | -42.29% | -93.19% | -106.70% |
Return on Capital Employed (ROCE) | 6.30% | 6.30% | 5.00% | -6.70% | -9.40% | -15.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.78% | 5.43% | 0.96% | -0.35% | -0.62% | -0.67% |
FCF Yield | 5.88% | 2.93% | 1.64% | 0.02% | 0.03% | -0.39% |
Buyback Yield / Dilution | 3.84% | 2.57% | -4.24% | -4.38% | -2.97% | -4.56% |